Details werden geladen...
UPDATE: Endogenex Announces Full Enrollment of the ReCET Clinical Study | The Manila Times
350 Patients Enrolled Across Sites in the United States and Australia, Advancing the Path to FDA Approval of a Novel Endoscopic Treatment for Type 2 Diabetes
Ähnliche Seiten
Endogenex Announces Full Enrollment of the ReCET Clinical Study | The Manila Times
https://www.manilatimes.net/2026/07/07/tmt-newswire/globenewswire/endogenex-announces-full-enrollment-of-the-recet-clinical-study/2379748Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial | The Manila Times
https://www.manilatimes.net/2026/06/16/tmt-newswire/globenewswire/pasithea-therapeutics-announces-amendments-to-clinical-study-protocol-for-phase-11b-nf1-clinical-trial/2366377
Nuance Pharma Announces IND Clearance for Actair® Pivotal Clinical Trial in China | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/pr-newswire/nuance-pharma-announces-ind-clearance-for-actair-pivotal-clinical-trial-in-china/2349777NBPE Announces April Monthly NAV Update | The Manila Times
https://www.manilatimes.net/2026/05/27/tmt-newswire/globenewswire/nbpe-announces-april-monthly-nav-update/2352306NBPE Announces Capital Allocation Framework Update | The Manila Times
https://www.manilatimes.net/2026/06/01/tmt-newswire/globenewswire/nbpe-announces-capital-allocation-framework-update/2355425